Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women. [electronic resource]
Producer: 20150828Description: 127-35 p. digitalISSN:- 1537-6591
- Adolescent
- Adult
- Antibodies, Viral -- blood
- Brazil
- CD4 Lymphocyte Count
- Drug-Related Side Effects and Adverse Reactions
- Female
- HIV Infections -- complications
- HIV-1 -- isolation & purification
- Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
- Humans
- Middle Aged
- Papillomaviridae -- immunology
- Papillomavirus Infections -- prevention & control
- Papillomavirus Vaccines -- adverse effects
- South Africa
- United States
- Vaccination -- adverse effects
- Viral Load
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.